A new trading day began on Friday, with Immunome Inc (NASDAQ: IMNM) stock price down -11.09% from the previous day of trading, before settling in for the closing price of $11.14. IMNM’s price has ranged from $6.93 to $30.96 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 18.61%. With a float of $50.90 million, this company’s outstanding shares have now reached $62.42 million.
The extent of productivity of a business whose workforce counts for 55 workers is very important to gauge. In terms of profitability, gross margin is 88.22%, operating margin of -3134.4%, and the pretax margin is -3014.59%.
Immunome Inc (IMNM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immunome Inc is 18.46%, while institutional ownership is 82.32%. The most recent insider transaction that took place on Sep 19 ’24, was worth 230,224. In this transaction Chief Financial Officer of this company sold 14,380 shares at a rate of $16.01, taking the stock ownership to the 47,476 shares. Before that another transaction happened on Sep 19 ’24, when Company’s Officer proposed sale 14,380 for $16.01, making the entire transaction worth $230,211.
Immunome Inc (IMNM) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.15 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.58 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.61% per share during the next fiscal year.
Immunome Inc (NASDAQ: IMNM) Trading Performance Indicators
Here are Immunome Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 54.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.12, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -3.00 in one year’s time.
Technical Analysis of Immunome Inc (IMNM)
The latest stats from [Immunome Inc, IMNM] show that its last 5-days average volume of 1.21 million was superior to 0.77 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 9.99%. Additionally, its Average True Range was 0.86.
During the past 100 days, Immunome Inc’s (IMNM) raw stochastic average was set at 3.76%, which indicates a significant decrease from 6.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.10% in the past 14 days, which was higher than the 67.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.12, while its 200-day Moving Average is $16.19. Now, the first resistance to watch is $10.85. This is followed by the second major resistance level at $11.80. The third major resistance level sits at $12.41. If the price goes on to break the first support level at $9.30, it is likely to go to the next support level at $8.69. The third support level lies at $7.74 if the price breaches the second support level.
Immunome Inc (NASDAQ: IMNM) Key Stats
With a market capitalization of 549.70 million, the company has a total of 62,417K Shares Outstanding. Currently, annual sales are 14,020 K while annual income is -106,810 K. The company’s previous quarter sales were 2,360 K while its latest quarter income was -36,120 K.
